For Researchers

SPRINTT and the involvement of stakeholders: strategy and structure

R. Le Lain, C. Ignaszewski, I. Klingmann, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

The present article describes the SPRINTT workpackage activities aimed at engaging the scientific discussion on the physical frailty and sarcopenia with the EMA as one of its interlocutor acknowledging the need to collaborate on this topic to foster a productive dialogue.

The “Sarcopenia and Physical fRailty IN older people: multicomponenT Treatment strategies” (SPRINTT) project: advancing the care of physically frail and sarcopenic older people

R. Bernabei, L. Mariotti, P. Bordes, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

The absolute and relative number of people aged 65+ is on a sharp rise worldwide. Such a demographic transition is certainly a desirable result of the magnificent combination of socioeconomic development, technological, and medical advancements, and the establishment of solid public health systems.

Biomarkers for physical frailty and sarcopenia

R. Calvani, F. Marini, M. Cesari, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

This review provides an overview of currently available biological markers for PF and sarcopenia, as well as a critical appraisal of strengths and weaknesses of traditional procedures for biomarker development in the field. A novel approach for biomarker identification and validation, based on multivariate methodologies, is also discussed.

 

Nutrition, frailty, and sarcopenia

A. J. Cruz-Jentoft, E. Kiesswetter, M. Drey, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

This brief review explores the role of energy and protein intake and other key nutrients on muscle function.

Physical frailty and sarcopenia (PF&S): a point of view from the industry

S. Del Signore and R.Roubenff

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

We agree with regulators that better characterization of subpopulations, not only in elderly patients, can improve the benefit risk ratio of medicines. At the same time, we believe it is in the public health interest to develop novel drugs indicated for specific geriatric conditions.

Possibilities of ICT-supported services in the clinical management of older adults

M. Vollenbroek-Hutten, S. Jansen-Kosterink, M. Tabak, et al.

Aging Clin Exp Res Epub 2017 Feb 10

CLICK HERE TO READ THE FULL TEXT

Aim of this article is to describe the possible field of application for ICTsupported services in the management of older adults, in particular those with functional impairment.

Pages